1 ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова», Москва, Россия; 2 ФГБУ «Национальный медицинский исследовательский центр эндокринологии» Минздрава России, Москва, Россия Обоснование. Нарушение ранозаживления и формирование диабетической стопы, тяжелого инвалидизирующего ослож-нения сахарного диабета, сопровождается поражением нервной системы и/или ишемией. Цель исследования -изучение влияния нарушений периферической иннервации на регуляцию репарации тканей в стреп-тозотоциновой модели сахарного диабета у крыс. Материал и методы. Исследование выполняли на 70 самцах белых беспородных крыс. Животным наносили рану через 42 дня после моделирования сахарного диабета инъекцией стрептозотоцина (группа СД; для снижения смертности эта группа полу-чала инсулин Левемир в дозе 2 Ед/кг в физиологическом растворе подкожно) либо после инъекции цитратного буфера (группа ЦБ). Забор проб кожи проводили на 8, 16 и 24-е сутки после моделирования раны. У всех животных оценивали болевую чув-ствительность. Полученные фрагменты кожи фиксировали, дегидратировали и заливали парафином по стандартной методике. Срезы окрашивали гематоксилином и эозином, для иммуногистохимического окрашивания использовали антитела, специфич-ные к Ki-67, α 1 -, β 1 -и β 2 -адренорецепторам. В качестве дополнительной группы контроля использовали интактных животных. Результаты. В группе СД время отдергивания хвоста у крыс на 56-е сутки увеличивалось по сравнению с группой кон-троля (р=0,017). В группе ЦБ прослеживалась тенденция к более быстрому заживлению раны, чем у животных с СД, хотя из-за большого разброса данных у крыс группы СД различия не достигали статистической значимости (p=0,64). Интенсив-ность окрашивания на Ki-67 в группе СД была ниже (р=0,045). В отдаленных от раны участках кожи крыс группы ЦБ на-блюдалось снижение плотности β 2 -адренорецепторов. Заключение. Полученные данные не позволяют связать изменения иннервации с нарушением процесса репарации тканей у крыс со стрептозотоциновым диабетом. Background. Wound healing disorders and formation of diabetic foot, a severe disabling complication of diabetes mellitus, are accompanied by nervous system impairment and/or ischemia. Objective -the study was aimed at assessing the effect of peripheral innervation disorders on the regulation of tissue repair in the streptozotocin-induced rat model of diabetes mellitus. Material and methods. The study was carried out in male white outbred rats (n=70). The animals were wounded 42 days after induction of diabetes by injecting streptozotocin (diabetes group; this group received insulin Levemir at a dose of 2 units/kg in saline subcutaneously to reduce mortality), or after injection of citrate buffer (CB group). Skin samples were taken on day 8, 16, and 24 after wound modeling. Pain sensitivity was assessed in all animals. The resulting skin fragments were fixed, dehydrated, and embedded in paraffin according to standard procedures. Sections were stained with hematoxylin and eosin, antibodies specific for Ki-67, α 1 , β 1 , and β 2 -adrenoreceptors were used for immunohistochemical staining. Intact animals were used as an additional control group. Results. Tail withdrawal time measured on day 56 was higher in DM group rats as compared to the control group (p=0.017). CB group demonstrated a tendency towards more rapid wounds healing than diabetic animals, although the difference was not statistically significant due to wide scatter of data in the DM group (p=0.64). The intensity of staining for Ki67 was lower in the DM group (p=0.045). Reduced density of β 2 -adrenoreceptors was observed at the areas remote from the wound in CB group rats. Conclusion The results show no correlation between altered innervation and impaired tissue repair in rats with streptozotocininduced diabetes.
BACKGROUND
Today, the number of people with diabetes mellitus in the world is over 460 million. As estimated by the International Diabetes Federation, this fi gure will increase to 642 million by 2040 [1] .
Diabetes mellitus is accompanied by complications such as the diabetic foot syndrome (DFS). Persistent lower extremity ulceration is one of the key symptoms of this syndrome [2] . As the ulcers are accompanied by neuropathy, ischemia, and are persistently traumatized, they are hardly curable and increase the risk of amputation, patients' disability, and death [3] . Therefore, it is very important to study the pathogenetic aspects of chronic wound formation in patients with diabetes mellitus and the potential methods for wound treatment.
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Special focus is currently placed on investigating the eff ect of the nervous system on the key wound healing mechanisms, especially on proliferation and migration of keratinocytes, the main cells of human skin [4] .
There are two main factors making the research into the wound healing mechanisms in patients with diabetes mellitus challenging. First, skin has its own nonneuronal catecholaminergic system [7] . Second, keratinocyte response depends on the intracellular mediator system [6] [7] [8] [9] . It has been proved in cell culture experiments that β 2 -adrenergic receptors (β 2 АР) play a role in regulation of keratinocyte life cycle. These receptors are transmembrane proteins bound to G proteins, which are abundantly expressed in undiff erentiated human skin keratinocytes. Whether the intracellular cAMP level will increase or decrease depends on what G-protein α subunit (Gαs or Gαi) is expressed in the cell. Stimulation of β 2 АР enhances keratinocyte galvanotaxis, migration, proliferation, and differentiation. The presence and impact of other subtypes of adrenergic receptors has been less studied. The data obtained in cells do not take into account the regulatory effects of the organism, changes in the metabolic rate of mediators, nerve ending density, and severity of diabetic neuropathy.
It has been demonstrated that keratinocytes cultured in a glucose-rich medium are characterized by disrupted proliferation and migration (expression of integrin α3, the keratinocyte growth factor, is downregulated). These cells form incomplete gap junctions; the oxidative stress and level of apoptosis are elevated in them. Angiogenesis in tissues surrounding the keratinocytes is disrupted, matrix metalloproteinases are overproduced, and the infection risks are high in patients with diabetes mellitus [10] [11] [12] . All these factors contribute to the formation of chronic non-healing wounds. However, we have found no comprehensive studies focused on the eff ect of neuropathy on wound healing in diabetes mellitus in the available literature.
OBJECTIVE
This study was aimed at investigating the development of neuropathy as a potential mechanism for impaired wound healing in the streptozotocin-induced rat model of diabetes mellitus.
METHODS
T he study was carried out in male white outbred rats weighing 350 ± 25 g (n = 70). The animals were kept in the vivarium with controlled illumination (12 hour light/12 hour dark cycle) and free access to food and water. The rats were randomly assigned into groups according to their body weight and heart rate variability.
Diabetes mellitus was simulated using a single intraperitoneal injection of streptozotocin (65 mg/kg) in cold 0.1 M citrate buff er (pH = 4.5, t = +4°С) [3] . Blood glucose level was measured on day 3. The animals with glucose level < 15 mM/mL were removed from the experiment. The day of diabetes mellitus verifi cation was considered day 1 of its development (the DM group). Next, throughout the entire experiments, animals in this group received a subcutaneous supporting injection of insulin detemir (Levemir®) at a dose of 2 units/kg in saline once daily, in the fi rst half of the day. The insulin dose was preselected so that the animals would have signifi cant hyperglycemia throughout the day.
Rats given a single intraperitoneal injection of cold 0.1 M citrate buff er (pH = 4.5, t = +4°С) in a proportional volume (CB group, control) were used as a control. Streptozotocin or citrate buff er was injected in the second half of the day, when animals were least active. An additional group of intact animals (the IC group) was also studied.
Blood glucose levels of the rats were measured weekly using an iCheck® blood glucose meter.
Pain sensitivity (the time interval between the moment when animal's tail tip (2 cm) was submerged in water with a temperature of 55 °C and the time when animals fl icked their tails) was measured weekly.
On day 42, round excisional wounds 2 cm in diameter were made below the left shoulder blade using the scissors in the DM and CB groups narcotized with chloral hydrate. After several manipulations, chloral hydrate was replaced with diethyl ether as chloral hydrate caused animals' death. The wound surface area was measured immediately after wounding and then every 3 days using the Universal Desktop Ruler® software. Skin specimens were collected on days 8, 16, and 24 after wound modelling. In the IC group, skin specimens were collected from 4-month-old animals. At each time point, skin specimens were collected in 10 animals in each group.
The resulting skin fragments were fi xed, dehydrated, and embedded in paraffi n according to the standard procedure. The samples were cut so that the microspecimen contained the wound defect and the adjacent non-damaged skin. Slices were stained with hematoxylin and eosin according to the standard procedure. Primary anti-rabbit antibodies (Abcam), HRP-conjugated secondary antibodies (goat anti-rabbit, Abcam), and the DAB imaging system were used for immunohistochemical staining to detect Ki67, α 1 , β 1 and β 2 adrenergic receptors. The slices were analyzed using a Zeiss Imager A1 Axio light microscope (Zeiss, Germany); the images were obtained using the AxioVision 3.5 software (Zeiss, Germany). The relative staining density was measured using the ImagePro software and compared to the negative control (the specimens stained in the absence of primary antibodies).
Experiment conditions
The experiment was conducted at the Division of Physiology and General Pathology, Faculty of Fundamental Medicine of the Lomonosov Moscow State University. 
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Statistical analysis
The Statistica 10.0 and IBM SPSS Statistics 23.0 software packages were used for statistical analysis. The survival was evaluated using the Cox model in which data incompleteness is allowed [2] . Repeated measures ANOVA was employed to evaluate the dynamics of wound healing and changes in pain sensitivity [2] . The expression densities of diff erent proteins were compared using multivariate analysis of variance on a mixed linear model (the Fisher's Least Signifi cant Diff erence test). The diff erences were considered statistically signifi cant at p < 0.05.
RESULTS
Overall well-being of animals
A single streptozotocin injection caused diabetes mellitus in rats on day 3 post-injection: the blood glucose level was 4-7 times higher than at baseline (6.2 mM) and remained elevated throughout the entire experiment. Animals with diabetes received insulin daily to increase their survival. Three out of 70 rats died during the entire experiment. The body weight of rats at baseline was 367 ± 55 g in the DM group; 372 ± 73 g in the CB group; and 360 ± 84 g in the IC group. Despite the supporting insulin therapy, weight loss in animals in the DM group gradually increased and was 25% by the end of the experiment. Contrariwise, the average weight of animals in the CB group increased by 20% by the end of the experiment (р < 0.01).
Dynamics of pain sensitivity
The tail fl ick test was carried out to evaluate the development of neuropathy. In animals in the CB and IC groups, the hot-water-immersion (55 °C) tail-fl ick latencies were almost identical: the average latency was 1.7±0.3 s. This latency gradually increased after modelling of DM, starting with day 7, and was 2.9±0.4 s (р= 0.017) by day 56.
Dynamics of wound healing
There were almost no diff erences in the dynamics of wound healing in rats in the DM and CB groups (р = 0.672). However, this could be related to a signifi cant variation in wound size in the DM group (Fig. 1) . Unlike in the DM group, the wound was completely healed by day 24 in the CB group.
Morphological and immunohistochemical analysis of wound healing
Epidermis of normal thickness, with clearly pronounced basal, spinous, and granular layers, was visualized in skin slices stained with hematoxylin and eosin in intact rats (Fig. 2a) .
On day 8 post-wounding, most of the wound surface was closed by granulation tissue intensively infi ltrated with infl ammatory cells (neutrophils, macrophages, and lymphocytes) (Fig. 2b) . The granulation tissue was covered with a layer consisting of necrotic masses. The regenerating epidermis margin was often thickened.
On day 16, the infl ammation subsided and signs of acute wound disappeared. Most of the wounds were covered with granulation tissue; epidermis at wound margin was signifi cantly thickened (Fig. 2c) . Cicatricial fi brous tissue was formed under the nascent epidermis. Wound re-epithelization was completed by day 16 in some rats in the CB group but not in the DM group.
The fi brous cicatrix lined with a thin epidermis layer was formed on day 24 after wound modeling (Fig. 2d) . In some rats in the DM group, complete skin regeneration did not take place during this period.
Immunohistochemical staining
The general view of immunohistochemically stained specimens is shown in Fig. 3 .
Skin keratinocytes in the IC rats largely expressed Ki67, a cell proliferation marker, which corresponds to high regenerative activity of the epidermis. Wounding of rats in the CB group had a negligible short-term eff ect on regenerative activity. On day 24 of wound healing, when re-epithelization was completed in all rats in this group, expression of Ki67 marker signifi cantly decreased both in the wound margin and in the relatively distant skin regions as compared to the previous time points, to intact animals, and to rats in the DM group (Fig. 4) .
In the DM group, Ki67 expression changed significantly at both locations neither on day 8 nor day 16; however, Ki67 expression at wound margin increased on day 24 compared to the IC (р = 0.036) and CB groups (р = 0.041), as well as to the previous time point (р = 0.028).
At most time points, Ki67 expression levels did not diff er signifi cantly in the wound center and at a certain distance from it both in the DM and CB groups. Only on day 24, the intensity of Ki67 staining in the wound center in the DM group was higher than that in the distant epidermal region (Fig. 5) .
Hence, expression of the proliferation marker at the wound margin in the DM group increased on day 24 postwounding (p = 0.04), being indicative of regeneration intensifi cation. Meanwhile, expression of the marker in the CB group decreased statistically signifi cantly on day 24 as wound re-epithelization was completed by this time (р = 0.031).
Epidermis stained with antibodies specific to β 1 -and α 1 -adre nergic receptors was detected in none of the groups, including the IC group, which may indicate that these adrenergic receptors are not expressed in rat keratinocytes. On the other hand, β 2 -adrenergic receptors were signifi cantly expressed in keratinocytes in all groups of animals, including the IC group. It should be mentioned that positively stained cells were predominantly located within the basal layer of epidermis (Fig. 2b) .
On days 8 and 16, expression of β 2 -adrenergic receptors did not diff er between the groups and skin regions. Their expression was downregulated in distant skin regions in the CB group (р = 0.046) on day 24 (Fig. 6) .
DISCUSSION
Neuropathy is one of the possible mechanisms responsible for disruption of wound healing in the streptozotocin-induced rat model of diabetes mellitus.
The results of the pain-sensitivity test demonstrated that rats in the DM group develop peripheral neuropathy that aff ects sensitive nerve endings during the wound-healing period under study [11, 12] . The morphological changes in animals' skin and the immunohistochemical data agree with the fact that animals develop neuropathy, so we can infer that these changes are interrelated.
We observed no statistically signifi cant diff erences between the rates of healing of the wound created on day 42 after the rats in the control (CB) and DM groups developed hyperglycemia. However, the wound size was reduced over time, the intragroup variation decreased, and complete wound healing was observed by day 24 postwounding in all rats in the CB group. Animals in the DM group had both higher and lower wound healing rates; however, complete wound healing by 24 days post-wounding was observed in none of rats in this group. This fact increased the intragroup variation, which impeded the detection of diff erences between the CB and DM groups. The diff erent wound healing rates in rats with DM can be caused by diff erences in high blood glucose level, which depends on sensitivity of pancreatic beta cells to streptozotocin.
When histological specimens were examined using a light microscope, the image of acute wound was gradually replaced with that of wound healing by secondary intention: the leukocyte infi ltration was reduced, the wound healing area was formed, new vessels were formed, and connective tissue fi lled the wound. In the CB group, wound repair was completed on day 24 post-wounding (day 56 since experiment initiation). All healing stages were slowed down in the DM group; the wound was not closed in most of animals in this group by the end of the experiment. Ki67 staining revealed the high level of proliferative activity in skin of intact rats. Wound modeling did not alter the proliferation level in the CB group neither in the skin area distant from the wound margin nor in the wound margin. The total proliferation level at the wound site decreased when the wound was completely healed. Interestingly, Ki67 expression in the wound margin in DM group animals with a non-healed defect increased by day 24 after wound modelling. This result demonstrates that skin is repaired in healthy rats due to selective changes in proliferative activity of various keratinocyte subtypes: the repair of healthy skin in the deeper skin layers under the thin layer of epidermis continues as the wound is closed. The Ki67 of keratinocytes decreases simultaneously. It seems likely that activation of the population of keratinocytes involved in wound healing is disrupted in animals with DM, so the baseline proliferative activity turns out to be insuf- fi cient to heal the defect and an increase in the Ki67 level is observed by day 24 post-wounding.
We have not revealed any correlation between diabetes mellitus, the wound healing stages, and adrenergic receptor density in rat epidermis. No signifi cant intergroup diff erences in staining density of β 2 -adrenergic receptors in keratinocytes were observed. The reduced receptor expression in skin distant from the wound in CB group rats has not been interpreted yet. Overall, it can be inferred that the density of β 2 -adrenergic receptors in rats with diabetes mellitus is not changed during wound healing. Nevertheless, further research into this problem is needed to draw any specifi c conclusions on whether or not peripheral innervation is altered during wound healing in rats with diabetes mellitus. This research needs to include evaluation of the status of other components of the sympathetic and parasympathetic nervous system in the skin.
CONCLUSIONS
This study allowed us to obtain new information about wound healing in the streptozotocin-induced rat model of diabetes mellitus. According to the proposed protocol, rats receiving supporting insulin therapy developed diabetes mellitus that did not cause animal death during 56 days. Pain sensitivity decreased gradually, which was especially clearly seen by day 56 of the experiment. The results of morphological examination demonstrate that wound reepithelialization was slowed down in rats with DM. In the fi nal point of the study, proliferative activity of keratinocytes in the wound margin increased in these rats, while in the CB group epithelization was completed by this time point and proliferative activity was reduced. Changes in β 2 -adrenergic receptor density in rats were observed neither after diabetes mellitus was induced nor during wound healing.
Studies focused on innervation density in skin along the wound margin, concentration of neurotransmitter metabolites, and broadening the range of investigated neuronal and non-neuronal systems regulating wound healing will provide an integrated understanding of the processes that take place in chronic diabetic wounds. Furthermore, they will allow one to fi nd novel potential therapy targets and eventually to improve quality of medical aid rendered to patients with diabetic foot syndrome. Figure 2 . Morphology of rat skin specimens stained with hematoxylin and eosin. The figure is available in the full-color inset and online:
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Fig. 3. Examples of immunohistochemical staining.
DAB: a -Negative control: only a strip of the stratum corneum is stained nonspecifically; b -staining with antibodies specific to β2 adrenergic receptors, wound margin, stained cells predominantly localize in the deep epidermal layers; c -staining with antibodies specific to Ki67, wound margin. 
